Active substanceGlucosamine + chondroitin sulfateGlucosamine + chondroitin sulfate
Similar drugsTo uncover
  • ARTRA®
    pills inwards 
    Unipharm, Inc.     USA
  • Arthravir®-complex-INCAMFARM®
    capsules inwards 
    TRIVIUM-XXI, LLC     Russia
  • KONDRONOVO®
    capsules inwards 
  • Structum®
    capsules inwards 
  • Tazan®
    pills inwards 
    MS-VITA, LLC     Russia
  • Tazan®
    pills inwards 
    MS-VITA, LLC     Russia
  • Teraflex®
    capsules inwards 
    BAYER, AO     Russia
  • Chondroglucose
    gel externally 
    SYNTHESIS, OJSC     Russia
  • Chondroglucose
    pills inwards 
    MS-VITA, LLC     Russia
  • Hondroflex
    capsules inwards 
  • Dosage form: & nbspThe tablets covered with a film membrane.
    Composition:

    Active substances: glucosamine sodium sulfate chloride (in terms of glucosamine sulfate) - 500 mg; chondroitin sodium sulfate - 500 mg;

    Excipients: colloidal silicon dioxide (Aerosil) - 8.5 mg Calcium stearate - 17.0 mg Talc - 51.0 mg Crospovidone (Kollidon CL) - 170.0 mg, povidone low molecular weight (low molecular weight polyvinylpyrrolidone medical 12600 + 2700) - 86 0 mg potato starch - 4.5 mg, ludipress (composition: lactose monohydrate - 91- 95% povidone - 3-4% crospovidone - 3.4%) - up to obtain core weight 1,700 mg;

    Shell composition: Hypromellose (hydroxypropyl) - 27.2 mg Propylene Glycol - 2.5 mg macrogol (polyethylene glycol 4000) - 23.8 mg Titanium dioxide 16.5 mg.

    Description:
    Biconvex tablets are oval, covered with a film membrane from white to almost white. Roughness of the surface of tablets is allowed.

    Pharmacotherapeutic group:Reparation of tissue stimulant.
    ATX: & nbsp

    M.01.A.X   Other non-steroidal anti-inflammatory drugs

    Pharmacodynamics:
    Stimulates the regeneration of cartilaginous tissue. Glucosamine and chondroitin sulfate are involved in the synthesis of connective tissue, helping to prevent cartilage destruction processes and stimulating tissue regeneration. The introduction of exogenous glucosamine enhances the production of the cartilaginous matrix and provides non-specific protection against chemical damage to the cartilage. Glucosamine in the form of a sulfate salt is a precursor of hexosamine, and the sulfate anion is necessary for the synthesis of glycosaminoglycans. Another possible function of glucosamine is to protect the damaged cartilage from metabolic destruction caused by non-steroidal anti-inflammatory drugs and glucocorticosteroid, as well as its own moderate anti-inflammatory effect.
    Chondroitin sulfate, regardless of whether it is absorbed in an intact form or as separate components,serves as an additional substrate for the formation of a healthy cartilage matrix. Stimulates the formation of hyaluronone. synthesis of proteoglycans and collagen type II, and also protects hyaluronone from enzymatic cleavage (by suppressing the activity of hyaluronidase) and the damaging effect of free radicals; maintains the viscosity of the synovial fluid, stimulates mechanisms of cartilage repair. In the treatment of osteoarthritis, it alleviates the symptoms of the disease and reduces the need for non-steroidal anti-inflammatory drugs.
    Pharmacokinetics:
    Glucosamine: bioavailability with oral intake - 25% (effect of "first passage" through the liver).
    Distributed in tissues: the highest concentrations are found in the liver, kidneys and articular cartilage. About 30% of the dose is persistently persistent in bone and muscle tissue. It is excreted mainly by the kidneys in unchanged form; partially-the intestine. Half-life is 68 h.
    Chondroitin sulfate: once taken at a dose of 0.8 g (or twice a day at a dose of 0.4 g), the concentration in the plasma increases for 24 hours. Absolute bioavailability is 12%.About 10 and 20% of the dose absorbed in the form of high and low molecular weight derivatives, respectively. The apparent volume of distribution is about 0.44 ml / g. It is metabolized by desulfurization. It is excreted by the kidneys. The half-life is 310 min.
    Indications:Osteoarthrosis I-III st.
    Contraindications:Hypersensitivity to the drug, children under 18 years of severe impaired renal function.
    Carefully:Bleeding, a tendency to bleeding, diabetes, bronchial asthma.
    Pregnancy and lactation:During pregnancy and during breastfeeding (lactation), the drug is not used.
    Dosing and Administration:Inside. Adults and children over 15 years: 1 tablet 2 times a day during the first three weeks; 1 tablet 1 time per day for the following weeks and months. Steady therapeutic effect is achieved when taking the drug for at least 6 months.
    Side effects:Dysfunction of the gastrointestinal tract (epigastric pain, bloating, constipation or diarrhea), dizziness, allergic skin reactions, headache, leg pain and peripheral edema, somnolence, insomnia, tachycardia, allergic reactions.
    Overdose:Symptoms: cases of overdose are unknown. Treatment: gastric lavage, symptomatic therapy.
    Interaction:Increases the absorption of tetracyclines, reduces the effect of semisynthetic penicillins and glucosamine. The drug is compatible with non-steroidal anti-inflammatory drugs and glucocorticosteroid. It is possible to increase the effect of anticoagulants, antiplatelet agents, fibrinolytic agents.
    Special instructions:If there are undesirable effects from the gastrointestinal tract, the dose of the drug should be reduced 2 times, and in the absence of improvement - cancel the drug. In the absence of a clinical effect after a treatment course of 4 tablets per day for 4 weeks, the question of clarifying the diagnosis should be resolved.
    Effect on the ability to drive transp. cf. and fur:Care must be taken when driving vehicles and engaging in other potentially hazardous activities requiring increased attention and speed of psychomotor reactions.
    Form release / dosage:
    The tablets covered with a film membrane 500 mg + 500 mg.
    Packaging:
    5, 15 tablets per contour cell package.
    For 30, 60 or 90 tablets in cans of polymeric.
    Each can, 6, 12 or 18 contour cell packs of 5 tablets or 2, 4 or 6 contiguous cell packs of 15 tablets with instructions for medical use are placed in a pack of cardboard.
    Storage conditions:
    In the dark place at a temperature of no higher than 25 C.
    Keep out of the reach of children.
    Shelf life:3 years. Do not use after the expiration date printed on the package.
    Terms of leave from pharmacies:Without recipe
    Registration number:PL 001859
    Date of registration:27.09.2012
    Date of cancellation:2017-09-27
    The owner of the registration certificate:MS-VITA, LLC MS-VITA, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp27.09.2015
    Illustrated instructions
      Instructions
      Up